BCM
EVLO

Bridgeway Capital Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bridgeway Capital Management’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,265
Closed -$19K – 1478
2023
Q1 		$19K Hold
5,265
– – ﹤0.01% 1357
2022
Q4 		$170K Hold
5,265
– – ﹤0.01% 1124
2022
Q3 		$220K Buy
+5,265
New +$241K 0.01% 1124
2020
Q3 		– Sell
-3,425
Closed -$336K – 1373
2020
Q2 		$336K Sell
3,425
-3,250
-49% -$284K 0.01% 1007
2020
Q1 		$501K Hold
6,675
– – 0.01% 760
2019
Q4 		$542K Buy
+6,675
New +$747K 0.01% 950

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return